SRC and glioblastoma: In agreement with this finding, CPPs containing this sequence (TAT-Cx43-266-283) inhibited the oncogenic activity of c-Src [11], increased PTEN, reduced Akt activity and subsequently decreased human glioblastoma stem cell proliferation.